Compounds > 2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone
Page last updated: 2024-08-24

2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone and Cancer of Head

2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone has been researched along with Cancer of Head in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Callahan, K; Crain, SM; Forastiere, AA; Mattox, D; Thant, M; Van Echo, D; Von Hoff, DD; Wiernik, PH1

Other Studies

1 other study(ies) available for 2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone and Cancer of Head

ArticleYear
Phase II trial of aziridinylbenzoquinone (AZQ) in head and neck cancer.
    Cancer treatment reports, 1982, Volume: 66, Issue:12

    Topics: Adult; Aged; Aziridines; Azirines; Benzoquinones; Cyclohexenes; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged

1982